Sunhawk Vision Biotech, Inc. (TPEX:7759)
Taiwan · Delayed Price · Currency is TWD 32.00
-0.45 (-1.39%)
At close: Sep 14, 2026
Sunhawk Vision Biotech Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Cash & Equivalents | 349.82 | 401.02 | 111.4 | 175.07 |
Short-Term Investments | - | - | 91.4 | 53.5 |
Cash & Short-Term Investments | 349.82 | 401.02 | 202.8 | 228.57 |
Cash Growth | -23.15% | 97.75% | -11.28% | - |
Other Receivables | 10.76 | 9.62 | 5.36 | 2.33 |
Receivables | 10.76 | 9.62 | 5.36 | 2.33 |
Prepaid Expenses | 7.74 | 8.2 | 16.09 | 10.44 |
Other Current Assets | 0.06 | 0.16 | - | - |
Total Current Assets | 368.38 | 419 | 224.24 | 241.34 |
Property, Plant & Equipment | 5.72 | 8.46 | 13.37 | 8.98 |
Other Intangible Assets | 70.09 | 70.11 | 70.15 | 70.19 |
Other Long-Term Assets | 1.06 | 1.23 | 1.02 | 0.33 |
Total Assets | 445.24 | 498.81 | 308.78 | 320.85 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Accrued Expenses | 18.91 | 20.49 | 2.43 | 7.61 |
Current Portion of Leases | 3.35 | 4.14 | 3.76 | 0.76 |
Other Current Liabilities | 4.89 | 0.79 | 0.69 | 0.04 |
Total Current Liabilities | 27.15 | 25.42 | 6.87 | 8.42 |
Long-Term Leases | - | 1.41 | 5.72 | 2.87 |
Pension & Post-Retirement Benefits | 0.21 | 0.18 | - | - |
Total Liabilities | 27.36 | 27.01 | 12.6 | 11.29 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Common Stock | 703.42 | 700.68 | 632.18 | 211 |
Additional Paid-In Capital | 339.76 | 338.3 | 59 | - |
Retained Earnings | -621.57 | -567.18 | -394.8 | -93.75 |
Comprehensive Income & Other | -3.72 | - | -0.21 | 192.31 |
Shareholders' Equity | 417.89 | 471.8 | 296.18 | 309.56 |
Total Liabilities & Equity | 445.24 | 498.81 | 308.78 | 320.85 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Total Debt | 3.35 | 5.55 | 9.48 | 3.63 |
Net Cash (Debt) | 346.47 | 395.47 | 193.31 | 224.93 |
Net Cash Growth | -22.60% | 104.57% | -14.06% | - |
Net Cash Per Share | 4.94 | 5.66 | 3.10 | 3.64 |
Filing Date Shares Outstanding | 70.34 | 70.07 | 63.22 | 61.72 |
Total Common Shares Outstanding | 70.34 | 70.07 | 63.22 | 61.72 |
Working Capital | 341.23 | 393.58 | 217.37 | 232.93 |
Book Value Per Share | 5.94 | 6.73 | 4.69 | 5.02 |
Tangible Book Value | 347.8 | 401.69 | 226.03 | 239.38 |
Tangible Book Value Per Share | 4.94 | 5.73 | 3.58 | 3.88 |
Machinery | - | 5.25 | 4.99 | 5.57 |
Leasehold Improvements | - | 0.85 | 1.15 | 0.65 |